KYTX Kyverna Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 11, 2026
$6.22
· of 52w range
· above low
· to high
$5.3052w low
$13.6752w high
Market Cap (MRQ)
$383M
P/E
-1.7
EPS
$-3.64
your badges
52W Range
$5–$14
Analyst Rating
BUY
Price Target
$30
P/E
-1.7
ROE
-77.4%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
KYTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.22
Market Cap (MRQ)
$383M
P/E
-1.7
EPS
$-3.64
ROE
-77.4%
Debt/Equity (MRQ)
0.2
52W Range
$5–$14
KYTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-3.642023-12-31 → 2025-12-31
Free Cash Flow$-154M2024-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | KYTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -1.7 | · | · | · | |
| P/B (MRQ) | 2.3 | · | 3.0 | Overvalued | |
| EV / EBITDA (TTM) | -1.3 | · | · | · | |
| Price / FCF | -2.4 | · | · | · | |
| Price / Cash Flow | -2.4 | · | · | · | |
| Price / Tangible Book | 1.6 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | KYTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -53.9% | · | -50.5% | Weak | |
| ROE | -77.4% | · | -77.4% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | KYTX | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.2 | · | 0.1 | Above avg | |
| Current Ratio (MRQ) | 9.1 | · | 7.3 | Strong liquidity | |
| Quick Ratio | 7.7 | · | 5.9 | Strong liquidity | |
| Long-Term Debt / Equity (MRQ) | 0.2 | · | 0.1 | Above avg |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
8.7%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 18, 2026 | $-0.63 | $-0.69 | 8.9% |
| March 31, 2026 | May 19, 2026 | $-0.66 | $-0.77 | 13.9% |
| Dec. 31, 2025 | $-0.80 | $-0.88 | 8.6% | |
| Sept. 30, 2025 | $-0.85 | $-0.99 | 14.2% | |
| June 30, 2025 | $-0.97 | $-1.06 | 8.9% | |
| March 31, 2025 | $-1.03 | $-1.14 | 9.3% | |
| Dec. 31, 2024 | $-0.88 | $-0.85 | -2.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | $134M | $112M | $50M | |
| SG&A Expense | $36M | $30M | $12M | |
| Operating Expenses | $170M | $143M | $62M | |
| Operating Income | $-170M | $-143M | $-62M | |
| Interest Income | $9M | $15M | $2M | |
| Other Non-op | $-85.0K | $-90.0K | $-55.0K | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-161M | $-127M | $-60M | |
| EPS (Basic) | $-3.64 | $-3.33 | $-89.61 | |
| EPS (Diluted) | $-3.64 | $-3.33 | $-89.61 | |
| Shares (Basic) | 44,259,999 | 38,334,571 | 673,622 | |
| Shares (Diluted) | 44,259,999 | 38,334,571 | 673,622 | |
| EBITDA | $-168M | $-140M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $124M | $97M | $35M | |
| Short-term Investments | $155M | $189M | $23M | |
| Prepaid Expense | $4M | $5M | $3M | |
| Current Assets | $283M | $291M | $61M | |
| PP&E (Net) | $2M | $3M | $2M | |
| PP&E (Gross) | $5M | $7M | $5M | |
| Accum. Depreciation | $4M | $4M | $2M | |
| Other Non-current Assets | $5M | $3M | $3M | |
| Total Assets | $294M | $305M | $75M | |
| Accounts Payable | $5M | $5M | $4M | |
| Current Liabilities | $36M | $34M | $20M | |
| Capital Leases | $320.0K | $4M | $5M | |
| Total Liabilities | $62M | $38M | $26M | |
| Common Stock | $1.0K | $0 | · | |
| Retained Earnings | $-425M | $-264M | $-136M | |
| AOCI | $97.0K | $105.0K | $4.0K | |
| Stockholders' Equity | $232M | $267M | $-13M | |
| Liabilities + Equity | $294M | $305M | $75M | |
| Shares Outstanding | 60,389,893 | 43,214,918 | 1,250,103 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $2M | $2M | $2M | |
| Stock-based Comp | $10M | $8M | $2M | |
| Other Non-cash | $-4M | $3M | · | |
| Operating Cash Flow | $-154M | $-114M | $-52M | |
| CapEx | $5.0K | $2M | $621.0K | |
| Investing Cash Flow | $40M | $-161M | $-9M | |
| Stock Issued | $17M | $0 | · | |
| Net Stock Activity | $17M | · | · | |
| Financing Cash Flow | $141M | $337M | $58M | |
| Net Change in Cash | $27M | $62M | $-3M | |
| Taxes Paid | $0 | $0 | · | |
| Free Cash Flow | $-154M | $-116M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -53.9% | -67.1% | · | |
| ROE | -77.4% | -44.8% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 7.8 | 8.6 | · | |
| Quick Ratio | 7.7 | 8.5 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Book Value / Share | $3.85 | $6.17 | · | |
| Cash Flow / Share | $-3.47 | $-2.98 | · | |
| Cash / Share | $2.05 | $2.24 | · | |
| EPS (TTM) | $-3.64 | $-3.33 | $-89.61 |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-161M | $-127M | $-60M | |
| Market Cap | $568M | $162M | · | |
| P/E | -2.6 | -1.1 | · | |
| P/B | 2.4 | 0.6 | · | |
| P / Tangible Book | 2.4 | 0.6 | · | |
| P / Cash Flow | -3.7 | -1.4 | · | |
| P / FCF | -3.7 | -1.4 | · | |
| Earnings Yield | -38.7% | -89.0% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $25M | $30M | $30M | $30M | $36M | $37M | $33M | $29M | $27M | $22M | $17M | $14M | $10M | $9M | |
| SG&A Expense | $15M | $11M | $9M | $8M | $9M | $10M | $8M | $10M | $6M | $7M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $40M | $41M | $39M | $39M | $44M | $47M | $41M | $39M | $33M | $29M | $21M | $16M | $13M | $11M | |
| Operating Income | $-40M | $-41M | $-39M | $-39M | $-44M | $-47M | $-41M | $-39M | $-33M | $-29M | $-21M | $-16M | $-13M | $-11M | |
| Interest Expense | · | · | · | · | · | · | · | · | $39.0K | $44.0K | · | · | $46.0K | $44.0K | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $5M | $3M | $789.0K | $880.0K | $264.0K | $349.0K | |
| Other Non-op | $-18.0K | $-21.0K | $16.0K | $-53.0K | $-21.0K | $-27.0K | $4.0K | $-45.0K | $-23.0K | $-26.0K | $-32.0K | $-13.0K | $-7.0K | $-3.0K | |
| Net Income | $-38M | $-40M | $-38M | $-37M | $-42M | $-45M | $-37M | $-34M | $-29M | $-27M | $-21M | $-15M | $-13M | $-11M | |
| EPS (Basic) | $-0.63 | $-0.66 | $-0.79 | $-0.85 | $-0.97 | $-1.03 | $-0.74 | $-0.80 | $-0.67 | $-1.12 | $-33.38 | $-23.27 | $-20.86 | $-12.10 | |
| EPS (Diluted) | $-0.63 | $-0.66 | $-0.79 | $-0.85 | $-0.97 | $-1.03 | $-0.74 | $-0.80 | $-0.67 | $-1.12 | $-33.38 | $-23.27 | $-20.86 | $-12.10 | |
| Shares (Basic) | 60,896,872 | 60,434,200 | · | 43,415,367 | 43,225,365 | 43,215,577 | · | 43,155,858 | 43,125,709 | 23,754,062 | · | 664,656 | 627,589 | 921,260 | |
| Shares (Diluted) | 60,896,872 | 60,434,200 | · | 43,415,367 | 43,225,365 | 43,215,577 | · | 43,155,858 | 43,125,709 | 23,754,062 | · | 664,656 | 627,589 | 921,260 | |
| EBITDA | $-40M | $-41M | · | $-39M | $-44M | $-47M | · | $-39M | $-33M | $-29M | · | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $32M | $32M | $124M | $34M | $53M | $57M | $97M | $105M | $132M | $224M | $35M | · | · | · | |
| Short-term Investments | $168M | $204M | $155M | $137M | $158M | $186M | $189M | $217M | $215M | $146M | $23M | · | · | · | |
| Prepaid Expense | $7M | $5M | $4M | $4M | $3M | $5M | $5M | $4M | $3M | $6M | $3M | · | · | · | |
| Current Assets | $207M | $242M | $283M | $175M | $214M | $248M | $291M | $325M | $349M | $375M | $61M | · | · | · | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $2M | · | · | · | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $6M | $6M | $7M | $6M | $6M | $5M | $5M | · | · | · | |
| Accum. Depreciation | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | · | · | · | |
| Other Non-current Assets | $3M | $5M | $5M | $5M | $4M | $4M | $3M | $2M | $1M | $1M | $3M | · | · | · | |
| Total Assets | $220M | $257M | $294M | $187M | $227M | $261M | $305M | $339M | $363M | $390M | $75M | · | · | · | |
| Accounts Payable | $3M | $12M | $5M | $3M | $10M | $8M | $5M | $10M | $5M | $7M | $4M | · | · | · | |
| Current Liabilities | $23M | $30M | $36M | $34M | $40M | $33M | $34M | $31M | $23M | $22M | $20M | · | · | · | |
| Capital Leases | $7M | $7M | $320.0K | $1M | $2M | $3M | $4M | $5M | $6M | $6M | $5M | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | $296.0K | · | · | · | · | · | · | |
| Total Liabilities | $54M | $61M | $62M | $35M | $42M | $37M | $38M | $36M | $30M | $29M | $26M | · | · | · | |
| Total Debt | $25M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | · | · | · | $0 | · | · | · | · | · | · | · | |
| Retained Earnings | $-503M | $-465M | $-425M | $-387M | $-350M | $-308M | $-264M | $-226M | $-192M | $-163M | $-136M | · | · | · | |
| AOCI | $-142.0K | $-96.0K | $97.0K | $29.0K | $-20.0K | $-1.0K | $105.0K | $153.0K | $-37.0K | $-1.0K | $4.0K | · | · | · | |
| Stockholders' Equity | $166M | $196M | $232M | $152M | $184M | $224M | $267M | $303M | $334M | $361M | $-131M | · | · | · | |
| Liabilities + Equity | $220M | $257M | $294M | $187M | $227M | $261M | $305M | $339M | $363M | $390M | $75M | · | · | · | |
| Shares Outstanding | 61,570,247 | 60,532,500 | 60,389,893 | 43,794,087 | 43,244,930 | 43,218,873 | 43,214,918 | 43,167,337 | 43,146,852 | 43,115,244 | 1,250,103 | · | · | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $434.0K | $351.0K | $368.0K | $415.0K | $515.0K | $501.0K | $563.0K | $558.0K | $530.0K | $482.0K | $462.0K | $438.0K | $413.0K | $394.0K | |
| Stock-based Comp | $4M | $3M | $3M | $3M | $3M | $2M | $1M | $3M | $1M | $2M | $784.0K | $521.0K | $447.0K | $468.0K | |
| Other Non-cash | · | $-5M | · | · | · | $-3M | · | · | · | $-2M | · | · | · | · | |
| Operating Cash Flow | $-40M | $-42M | $-34M | $-43M | $-32M | $-45M | $-37M | $-27M | $-24M | $-26M | $-19M | $-11M | $-11M | $-11M | |
| CapEx | · | · | $-1.0K | $2.0K | $4.0K | $0 | $532.0K | $102.0K | $1M | $543.0K | $334.0K | $256.0K | $3.0K | $28.0K | |
| Investing Cash Flow | $36M | $-50M | $-17M | $23M | $29M | $6M | $29M | $676.0K | $-68M | $-123M | $32M | $-54M | $-3.0K | $14M | |
| Financing Cash Flow | $4M | $-101.0K | $141M | $1M | $-649.0K | $-414.0K | $-215.0K | $-152.0K | $-569.0K | $338M | $-1M | $35M | $25M | $-144.0K | |
| Net Change in Cash | $-388.0K | $-92M | $90M | $-19M | $-3M | $-40M | $-8M | $-27M | $-93M | $190M | $12M | $-30M | $14M | $2M | |
| Free Cash Flow | · | · | · | · | · | $-45M | · | · | · | $-26M | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -17.2% | -15.3% | · | -14.0% | -14.3% | -13.7% | · | -20.3% | -15.9% | -13.7% | · | · | · | · | |
| ROE | -21.9% | -18.9% | · | -16.2% | -16.2% | -15.3% | · | -22.8% | -17.3% | -14.8% | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.1 | 8.1 | · | 5.2 | 5.4 | 7.4 | · | 10.5 | 14.9 | 17.2 | · | · | · | · | |
| Quick Ratio | 8.7 | 8.0 | · | 5.1 | 5.3 | 7.3 | · | 10.4 | 14.7 | 16.9 | · | · | · | · | |
| Debt / Equity | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -857.3 | -667.2 | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.69 | $3.23 | · | $3.47 | $4.26 | $5.18 | · | $7.01 | $7.73 | $8.37 | · | · | · | · | |
| Cash Flow / Share | · | $-0.69 | · | · | · | $-1.04 | · | · | · | $-1.07 | · | · | · | · | |
| Cash / Share | $0.52 | $0.53 | · | $0.78 | $1.24 | $1.32 | · | $2.42 | $3.05 | $5.20 | · | · | · | · | |
| EPS (TTM) | $-2.93 | $-3.27 | · | $-3.59 | $-3.54 | $-3.24 | · | $-35.97 | $-58.44 | $-78.63 | · | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-153M | $-156M | · | $-161M | $-159M | $-145M | · | $-111M | $-92M | $-76M | · | · | · | · | |
| Market Cap | $549M | $522M | · | $263M | $133M | $83M | · | $211M | $324M | $1.07B | · | · | · | · | |
| Enterprise Value | $374M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -3.0 | -2.6 | · | -1.7 | -0.9 | -0.6 | · | -0.1 | -0.1 | -0.3 | · | · | · | · | |
| P/B | 3.3 | 2.7 | · | 1.7 | 0.7 | 0.4 | · | 0.7 | 1.0 | 3.0 | · | · | · | · | |
| P / Tangible Book | 3.3 | 2.7 | · | 1.7 | 0.7 | 0.4 | · | 0.7 | 1.0 | 3.0 | · | · | · | · | |
| P / Cash Flow | · | -12.6 | · | · | · | -1.9 | · | · | · | -42.0 | · | · | · | · | |
| Earnings Yield | -32.9% | -37.9% | · | -59.8% | -115.3% | -167.9% | · | -735.6% | -779.2% | -316.6% | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Net Income | $-161M | $-127M | $-60M |
| Diluted EPS | $-3.64 | $-3.33 | $-89.61 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Current Ratio | 7.8 | 8.6 | · |
| Quick Ratio | 7.7 | 8.5 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Free Cash Flow | $-154M | $-116M | · |
Institutional owners (13F) 133 filers · $371.2M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
133
Value held
$371.2M
New positions
34
Exited positions
22
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 34 (+7 vs prior Q) | 22 (+10 vs prior Q) | 40 (+7 vs prior Q) | 27 (-10 vs prior Q) | +3.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| GordonMD Global Investments LP | $37,821,328 | 4,244,818 | 10.19% | Shares |
| GILEAD SCIENCES, INC. | $36,763,720 | 4,126,119 | 9.90% | Shares |
| BlackRock, Inc. | $27,931,130 | 3,134,807 | 7.52% | Shares |
| Vida Ventures Advisors, LLC | $27,143,544 | 4,523,924 | 7.31% | Shares |
| Bain Capital Life Sciences Investors, LLC | $25,705,350 | 2,885,000 | 6.93% | Shares |
| AIGH Capital Management LLC | $24,910,552 | 2,795,797 | 6.71% | Shares |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $17,820,000 | 2,000,000 | 4.80% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $16,906,288 | 1,897,451 | 4.55% | Shares |
| VANGUARD GROUP INC | $16,743,815 | 1,781,257 | 4.51% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $9,352,537 | 1,049,430 | 2.52% | Shares |
| Insight Holdings Group, LLC | $8,812,471 | 989,054 | 2.37% | Shares |
| MORGAN STANLEY | $8,752,355 | 982,307 | 2.36% | Shares |
| STATE STREET CORP | $8,751,696 | 982,233 | 2.36% | Shares |
| Propel Bio Management, LLC | $7,869,294 | 883,198 | 2.12% | Shares |
| Woodline Partners LP | $7,531,846 | 845,325 | 2.03% | Shares |
| MILLENNIUM MANAGEMENT LLC | $5,700,440 | 639,780 | 1.54% | Shares |
| MBB PUBLIC MARKETS I LLC | $5,474,990 | 614,477 | 1.48% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4,455,000 | 500,000 | 1.20% | Shares |
| D. E. Shaw & Co., Inc. | $4,181,872 | 469,346 | 1.13% | Shares |
| WELLS FARGO & COMPANY/MN | $3,323,510 | 373,009 | 0.90% | Shares |
| UBS Group AG | $3,257,264 | 365,574 | 0.88% | Shares |
| GOLDMAN SACHS GROUP INC | $2,986,899 | 335,230 | 0.80% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $2,975,040 | 333,899 | 0.80% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2,848,224 | 319,666 | 0.77% | Shares |
| NORTHERN TRUST CORP | $2,809,805 | 315,354 | 0.76% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $2,767,731 | 310,632 | 0.75% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,514,304 | 282,189 | 0.68% | Shares |
| BANK OF AMERICA CORP /DE/ | $2,364,759 | 265,405 | 0.64% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,313,633 | 259,667 | 0.62% | Shares |
| Walleye Capital LLC | $2,188,180 | 245,587 | 0.59% | Shares |
| Y-Intercept (Hong Kong) Ltd | $2,159,668 | 242,387 | 0.58% | Shares |
| Nuveen, LLC | $2,082,650 | 233,743 | 0.56% | Shares |
| Burkehill Global Management, LP | $1,782,000 | 200,000 | 0.48% | Shares |
| Simplify Asset Management Inc. | $1,626,993 | 182,603 | 0.44% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,388,178 | 155,800 | 0.37% | Shares |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $1,335,609 | 149,900 | 0.36% | Shares |
| CITADEL ADVISORS LLC | $1,315,357 | 147,627 | 0.35% | Shares |
| TD Asset Management Inc | $1,298,027 | 145,682 | 0.35% | Shares |
| STIFEL FINANCIAL CORP | $1,247,088 | 139,965 | 0.34% | Shares |
| Qube Research & Technologies Ltd | $1,101,686 | 123,646 | 0.30% | Shares |
| CITADEL ADVISORS LLC | $1,098,603 | 123,300 | 0.30% | Call option |
| BARCLAYS PLC | $1,049,991 | 117,844 | 0.28% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $1,046,409 | 117,442 | 0.28% | Shares |
| WESBANCO BANK INC | $982,773 | 110,300 | 0.26% | Shares |
| Jump Financial, LLC | $903,046 | 101,352 | 0.24% | Shares |
| Bank of New York Mellon Corp | $893,504 | 100,281 | 0.24% | Shares |
| FMR LLC | $855,813 | 96,051 | 0.23% | Shares |
| Balyasny Asset Management L.P. | $855,788 | 96,048 | 0.23% | Shares |
| Susquehanna Portfolio Strategies, LLC | $791,609 | 88,845 | 0.21% | Shares |
| Squarepoint Ops LLC | $738,345 | 82,867 | 0.20% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Vida Ventures, LLC, VV Manager LLC, Vida Ventures GP III, L.L.C., Vida Ventures III, L.P., Vida Ventures III-A, L.P., Fred Cohen | May 3, 2024 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 17 insiders · 9 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Warner Weston Biddle | Chief Executive Officer | March 13, 2026 A | 58,000 | 0 | 0 | $0 |
| Gregory S. Martini | Chief Financial Officer | May 18, 2026 A | · | 0 | 0 | $0 |
| Marc Grasso | Chief Financial Officer | March 13, 2026 A | 10,000 | 0 | 0 | $0 |
| Ryan Alexander Jones | Chief Financial Officer | April 11, 2024 A | 55,950 | 0 | 0 | $0 |
| Christi Shaw | Executive Chairperson | May 27, 2026 F | 66,741 | 0 | 0 | $0 |
| Nadia Dac | Chief Commercial Officer | May 4, 2026 A | · | 0 | 0 | $0 |
| Naji Gehchan | Exhibit 24 - Power of Attorney Chief Medical & Development Officer | March 13, 2026 A | 18,000 | 0 | 0 | $0 |
| Mayobanex Pujols | Chief Technology Officer | Feb. 9, 2026 A | · | 0 | 0 | $0 |
| Karen Marie Walker | Chief Technology Officer | Dec. 15, 2025 M | 22,636 | 0 | 1 | $-292,776 |
| Mert Aktar | Director | May 27, 2026 A | 21,727 | 0 | 0 | $0 |
| Fred Cohen | Director | May 27, 2026 A | 21,727 | 0 | 0 | $0 |
| Ian T Clark | Director | May 27, 2026 A | 21,727 | 0 | 0 | $0 |
| Beth C Seidenberg | Director | May 27, 2026 A | 21,727 | 1 | 0 | $999,998 |
| Sravan Kumar Emany | Director | Feb. 24, 2026 A | 11,006 | 0 | 0 | $0 |
| Andrew Craig Miller | Director | Feb. 24, 2026 A | 11,006 | 0 | 0 | $0 |
| Daniel K Spiegelman | Director | May 29, 2025 A | 16,634 | 0 | 0 | $0 |
| Gilead Sciences, Inc. | 10% owner | Feb. 12, 2024 C | 4,126,119 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 19 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.07% | 142,141 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.03% | 4,379 SH | Oct. 2, 2026 | Daily |
| IBB · iShares Trust | 0.02% | 283,725 SH | Sept. 11, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 33,322 SH | Aug. 19, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 48,059 SH | Oct. 2, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 1,083,112 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 241,414 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 19,945 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 3,349 NS | July 31, 2026 | N-PORT |
| IWO · iShares Trust | 0.00% | 34,167 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 15,873 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 4,825 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 9,116 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 4,410 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 448,147 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1,403,697 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,918 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3,535 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 349,944 SH | Sept. 11, 2026 | Daily |
KYTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 12 analysts
BUY
Median target
$32.00
+414.5%
4 33.3%
Strong Buy
7 58.3%
Buy
1 8.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-10-01Mean target $30.40 +388.7%
← Below all targets
Current price $6.22
Low$25.00
Mean$30.40
High$33.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| KYTX | $568M | -2.6 | · | · | -77.4% | · |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| RZLT | $501M | -6.9 | · | · | -67.8% | · |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | · |
| EIKN | · | · | · | · | · | · |
| XFOR | $364M | -2.1 | 150.0% | -1218.5% | -83.2% | · |
| IRD | $140M | -2.5 | 29.1% | -349.3% | -302.2% | · |
| AGEN | $111M | · | 10.4% | -2.7% | 1.0% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 11, 2026